← Back to Search

Behavioral Intervention

Mindfulness-Based Stress Reduction for Hidradenitis Suppurativa

N/A
Recruiting
Led By Vivian Shi, MD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of HS
Subjects must be between the ages of 18-years and 89-years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1 of 8 week mbsr course intervention; week 4; end of mbsr course at week 8; and week 12.
Awards & highlights

Study Summary

This trial will look at how an 8-week mindfulness course affects life quality & HS severity in HS patients.

Who is the study for?
This trial is for adults aged 18 to 89 with Hidradenitis Suppurativa (HS), who can read and understand English. It's not suitable for non-English speakers or those who started psychotropic medications within the last three months.Check my eligibility
What is being tested?
The study tests an 8-week Mindfulness-Based Stress Reduction course, aiming to see if it improves life quality and reduces disease severity in patients with HS.See study design
What are the potential side effects?
Mindfulness programs are generally safe but may sometimes trigger or exacerbate emotional distress, particularly in individuals with a history of trauma or psychiatric conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Hidradenitis Suppurativa (HS).
Select...
I am between 18 and 89 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1 of 8 week mbsr course intervention; week 4; end of mbsr course at week 8; and week 12.
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 of 8 week mbsr course intervention; week 4; end of mbsr course at week 8; and week 12. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dermatology Quality of Life Index (DLQI scores)
Generalized Anxiety Disorder (GAD7)
Patient Health Questionaire (PHQ9)
Secondary outcome measures
Hidradenitis Suppurativa Quality of Life Index (HiSQOL)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention groupExperimental Treatment1 Intervention
All participants enrolled in the study will be enrolled in the Mindfulness-Based Stress reduction course. The MBSR course will consist of weekly sessions lasting two and a half hours, involving lecture, meditation, and self-reflection. The first MBSR course will be ready for 10-12 participants in November 2023. The following course will start every month thereafter. The courses will be held online over Zoom.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,323 Total Patients Enrolled
2 Trials studying Hidradenitis Suppurativa
30 Patients Enrolled for Hidradenitis Suppurativa
Vivian Shi, MDPrincipal InvestigatorUniversity of Arkansas
1 Previous Clinical Trials
14 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the qualifications to participate in this medical study?

"To be eligible to particpate in this trial, applicants must have a diagnosis of hidradenitis suppurativa and an age between 18-89 years old. Approximately 30 people are needed for completion of the study."

Answered by AI

Does the current trial encompass participants of advanced age?

"Eligibility for this trial is available to those aged 18-89, with 3 clinical trials aimed at minors and 35 studies tailored towards elderly persons."

Answered by AI

How many participants are included in the research study?

"Indeed, clinicaltrials.gov indicates that this trial is presently recruiting patients. The initial posting was on October 3rd 2023 and the details have been revised up to November 2nd 2023. 30 participants are being sought from a single site of origin."

Answered by AI

Are there any vacancies remaining in this clinical venture?

"Affirmative, clinicaltrials.gov data implies that this trial is currently accepting participants. The research was initially published on October 3rd 2023 and has been updated as recently as November 2nd 2023. Up to 30 patients are needed at one medical centre for the study's completion."

Answered by AI

Who else is applying?

What site did they apply to?
UAMS Dermatology Clinic
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

To be able to do this for me and others.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Mindfulness in Hidradenitis Suppurativa
2023. "Mindfulness in Hidradenitis Suppurativa". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06123429.
All > Hidradenitis Suppurativa
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top